Presentation at 2024 RBC Capital Markets Global Healthcare Conference

DRI Healthcare Comments on Juvmo's (tavapadon) FDA Approval

Tavapadon Conference Call

DRI Healthcare Announces US$316 Million Purchase of Tavapadon Royalty